The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation

Betty Maillot; Guillaume Bouzille; Jean-Yves Mabrut; Edouard Girard; Alexis Laurent; Francis Navarro; Alexandre Chebaro; Laurence Chiche; Francois Faitot; Laurent Sulpice; Eric Vibert; Karim Boudjema

doi:10.12659/AOT.935892

08 March 2022 : Original article

The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation

Betty Maillot^1ABCDEF*, Guillaume Bouzille^2C, Jean-Yves Mabrut^3B, Edouard Girard

^4B, Alexis Laurent^5B, Francis Navarro^6B, Alexandre Chebaro

^7B, Laurence Chiche^8B, Francois Faitot

^9B, Laurent Sulpice^1AB, Eric Vibert^10B, Karim Boudjema^1ACDEF

DOI: 10.12659/AOT.935892

Ann Transplant 2022; 27:e935892

Authors information Article notes Copyright and License information

¹Department of Hepatobiliary and Digestive Surgery, CHU Rennes, Pontchaillou Hospital, University of Rennes 1, Rennes, France
²Department of Medical Information and Medical Records, CHU Rennes, Pontchaillou Hospital, University of Rennes, INSERM, LTSI-UMR 1099, Rennes, France
³Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, University of Claude Bernard Lyon 1, Hospices Civils de Lyon. National Institute for Health and Medical Research (INSERM) Unit 1052/CNRS-5286, Lyon, France
⁴Department of Digestive Surgery and Emergency, CHU Grenoble Alpes, La Tronche Hospital, University of Grenoble Alpes, Grenoble, France
⁵Department of Digestive and Hepatobiliopancreatic Surgery, AP-HP, Henri Mondor Hospital, University of Paris-Est Créteil, Inserm, UMR-955, Paris, France
⁶Department of Hepatobiliary Digestive Surgery and Hepatic and Pancreatic Transplantation, CHU Montpellier, Saint Eloi Hospital, University of Medicine Montpellier-Nîmes, Montpellier, France
⁷Department of Digestive Surgery and Transplantation, CHU Lille, Huriez Hospital, University of Medicine Henri Warembourg, Lille, France
⁸Department of Hepatobiliary and Hepatic Transplantation, CHU Bordeaux, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France
⁹Department of General, Hepatic, Endocrine and Transplantation Surgery, CHU Strasbourg, Hautepierre Hospital, University of Strasbourg, Strasbourg, France
¹⁰Hepato-Biliary Center, AP-HP, Paul Brousse Hospital, University of Paris-Saclay, Paris, France

^*Corresponding Author: Betty Maillot, e-mail: [email protected]
^*Corresponding Author: Guillaume Bouzille, e-mail: [email protected]
^*Corresponding Author: Jean-Yves Mabrut, e-mail: [email protected]
^*Corresponding Author: Edouard Girard, e-mail: rf.elbonerg-uhc@1drarige
^*Corresponding Author: Alexis Laurent, e-mail: [email protected]
^*Corresponding Author: Francis Navarro, e-mail: rf.reilleptnom-uhc@orravan-f
^*Corresponding Author: Alexandre Chebaro, e-mail: [email protected]
^*Corresponding Author: Laurence Chiche, e-mail: [email protected]
^*Corresponding Author: Francois Faitot, e-mail: [email protected]
^*Corresponding Author: Laurent Sulpice, e-mail: [email protected]
^*Corresponding Author: Eric Vibert, e-mail: [email protected]
^*Corresponding Author: Karim Boudjema, e-mail: [email protected]

^AStudy design/planning
^BData collection/entry
^CData analysis/statistics
^DData interpretation
^EPreparation of manuscript
^FLiterature analysis/search

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 5 Patient, graft and preoperative characteristics after HT or OLT.

	HTn=59n (%) or median [IQR]	OLT*n=59n (%) or median [IQR]	P-value

Male gender	44 (74.6)	44 (74.6)	1.000
Age (years)	53 [42–59]	55 [44–60]	0.561
Previous LT	7 (11.9)	0 (0)	1.000
BMI (kg/m)	25.4 [23.4–27.1]	24.2 [22.1–26.5]	0.235
Performance status			0.002
0	1 (2.2)	0 (0.0)
1	9 (19.6)	0 (0.0)
2	9 (19.6)	18 (31.0)
3	22 (47.8)	31 (53.4)
4	5 (10.9)	9 (15.5)
Previous abdominal surgery	33 (58.9)	30 (50.8)	0.495
Previous permeable surgical shunts	6 (10.2)	0 (0.0)	0.027
LT indication
Cirrhosis	19 (32.2)	25 (42.4)	0.341
HCC	18 (30.5)	19 (32.2)	1.000
FH	2 (3.4)	3 (5.1)	1.000
PBC	0 (0.0)	2 (3.4)	0.496
PSC	1 (1.7)	2 (3.4)	1.000
Budd Chiari syndrome	4 (6.8)	4 (6.8)	1.000
Emergency retransplantation	4 (6.8)	0 (0.0)	0.119
Other	12 (20.3)	4 (6.8)	0.06
MELD score at LT	16 [14–22]	17 [13–23]	0.992
Waiting time (months)	4 [1–9]	5 [1–9]	0.887

Male gender	36 (65.5)	38 (60.3)	0.700
Age of graft (year)	49.2 (19.6)	54.5 (17.0)	0.103
ECD grafts	25 (40.3)	44 (68.8)	0.002

Duration of cold ischemia (min)	450 [396–545]	493 [402–600]	0.099
Intraoperative transfusion	57 (91.9)	55 (85.9)	0.431
Duration of surgery (min)	455 [408–594]	369 [303–450]	<0.001
^* Patients were paired to HT group on sex, age, recipient BMI, indication of transplantation, MELD score and cold ischemia time. HT – hemitransposition; OLT – orthotopic liver transplantation; IQR – interquartile range; LT – liver transplantation; BMI – body mass index; HCC – hepatocellular carcinoma; FH – fulminant hepatitis; PBC – primary biliary cirrhosis; PSC – primary sclerosing cholangitis; MELD – model for end stage liver disease; ECD – extended criteria donor.

Back to the Article

The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation

Your Privacy